CH BIOTECH SER (08037.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov25

China Biosciences Service's Boron Neutron Hospital System Achieves First Beam and Enters Final Clinical Debugging Stage

14:23

Aug27

CH BIOTECH SER released FY2025 Q1 earnings on August 27 (BJT), actual revenue HKD 19.44 M, actual EPS HKD -0.0164

15:00

CH BIOTECH SER released FY2025 Q2 earnings on August 27 During-Market BJT, actual revenue HKD 19.44 M, actual EPS HKD -0.0164

08:00

CH BIOTECH SER released FY2025 Semi-Annual Earnings on August 27 During-Market (BJT), actual revenue HKD 38.87 M, actual EPS HKD -0.0328

08:00

Aug19

CH BIOTECH SER to Release FY2025 Semi-Annual Earnings on August 27, 2025 (BJT)

01:38

Jul15

AXA 安盛 Signs MOU with China Biotech Service for Innovative Cancer Tech Cooperation

08:01

Schedules & Filings

Schedules

Filings

Aug27

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 19.44 M, Net Income -16 M, EPS -0.0164

Mar28

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 19.03 M, Net Income -59.11 M, EPS -0.0607

Aug26

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 16.22 M, Net Income -39.96 M, EPS -0.0414

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More